FDA approves new CAR-T cell therapy for multiple myeloma March 1, 2022 Auto Bot Oncology 0 The FDA approved carvykti, a new customized, cell-based treatment from Johnson & Johnson, for the treatment of multiple myeloma, Johnson & Johnson said Feb. 28.